Indian Council of Medical Research Partners on Vaccine R&D

The Indian Council of Medical Research (ICMR) entered into an agreement with the International Vaccine Institute (IVI) to collaborate on vaccine research and development. India will commit $500,000 annually for a stake in IVI. According to the Memorandum of Understanding, ICMR will focus on research and development of vaccines to combat various infectious diseases such as tuberculosis, malaria, chikungunya and influenza, among others.

Image of Vaccines
 ICMR director general Soumya Swaminathan outlined the partnership:
  • Vaccine candidates developed in IVI labs can be transferred to one of the companies in India for further development
  • IVI will facilitate further global testing of vaccine candidates developed in India’s labs by linking developers here with global partners
  • The partnership will help with capacity building for clinical trials within India
  • IVI will support in conducting phase II and III trials for the candidate, if required

Jerome H. Kim, director general of IVI said that India supplies 60% of the world’s vaccines for vaccine-preventable diseases and contributes up to 80% of the United Nations’ annual vaccine purchases, reports the Economic Times. “We look forward to having India’s representation on the IVI Board of Trustees, which will increase engagement with Indian academia and industry even further,” Kim said.

Be Sociable, Share!
Posted on by Gunjan Bagla
Gunjan Bagla
California-based management consultant Gunjan Bagla runs Amritt, a consulting firm helping American companies to succeed in India. Amritt is the trusted advisor for India market research, India business development, India market entry, Global Engineering, Global Technology Scouting, India R&D and Open Innovation. Gunjan is author of "Business in 21st Century India: How to Profit Today from Tomorrow’s Most Exciting Market" (Hachette Book Group, 2008), Amazon's top rated title on the subject. He has appeared as the India Expert on BBC Television, Bloomberg TV, Fox Cable Business and has been quoted in the New York Times, the Los Angeles Times, the Hollywood Reporter and Business Week for his expertise on India.


There are no comments yet...

Kick things off by filling out the form below.

Leave a Comment